CLINICAL ROLE -
FDA Approves Alemtuzumab for Relapsing Forms of Multiple Sclerosis
The FDA has approved alemtuzumab (Lemtrada) for the treatment of patients with relapsing forms of multiple sclerosis.
Read More
FDA Approves sNDA for Oral Erectile Dysfunction Treatment
The FDA has approved a supplemental new drug application for avanafil (Stendra) to treat erectile dysfunction in men.